Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
obesity drugs
Biotech
Novo CEO tells Pfizer to 'bid higher' if it wants to win Metsera
Amid the whiplash bidding war for obesity biotech Metsera, Novo Nordisk's CEO has, quite literally, told Pfizer to put its money where its mouth is.
Fraiser Kansteiner
Nov 7, 2025 10:00am
Lilly links amylin drug to 20% weight loss, races to phase 3
Nov 6, 2025 8:20am
FTC tells Novo that Metsera offer may violate US merger law
Nov 5, 2025 4:26pm
Terns mothballs obesity program after phase 2 data fall short
Oct 22, 2025 7:15am
Kailera raises hefty $600M to take Zepbound rival into ph. 3
Oct 14, 2025 9:20am
Skye's CB1 blocker fails to reduce weight in obesity study
Oct 6, 2025 7:55am